Mr. Anders Hedegaard has been President and Chief Executive Officer of Bavarian Nordic A/S since August 1, 2007. Prior to working for Bavarian Nordic A/S, Hedegaard worked as the Executive Vice President of Business Operations & International Marketing and Sales & Marketing for the pharmaceutical company ALK-Abelló A/S of Chr. Hansen Holding A/S. There he was a member of the executive management team from 2002 to November 2007. His previous management career includes executive and management positions with FOSS A/S and Novo Nordisk A/S. Mr. Hedegaard is currently also the Director of Origio A/S, and has been since April 2011. Mr. Hedegaard holds an MSc in chemical engineering specializing in molecular biology.
Announcing New Members of Concordia’s Advisory Council
Concordia is pleased to announce the appointment of a distinguished group of global leaders to its Advisory Council. Representing a diverse range of sectors, geographies, and areas of expertise, these individuals bring
